Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.19 (
ubiquitin-protein ligase
)
799
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although genome-wide association studies have identified the gene
RNF186
encoding an E3
ubiquitin-protein ligase
as conferring susceptibility to ulcerative colitis, the exact function of this protein remains unclear. In the present study, we demonstrate an important role for RNF186 in macroautophagy/autophagy activation in colonic epithelial cells and intestinal homeostasis. Mechanistically, RNF186 acts as an E3
ubiquitin-protein ligase
for EPHB2 and regulates the ubiquitination of EPHB2. Upon stimulation by ligand
EFNB1
(ephrin B1), EPHB2 is ubiquitinated by RNF186 at Lys892, and further recruits MAP1LC3B for autophagy. Compared to control mice,
rnf186
-/-
and
ephb2
-/-
mice have a more severe phenotype in the DSS-induced colitis model, which is due to a defect in autophagy in colon epithelial cells. More importantly, treatment with
ephrin-B1
-Fc recombinant protein effectively relieves DSS-induced mouse colitis, which suggests that
ephrin-B1
-Fc may be a potential therapy for human inflammatory bowel diseases.
...
PMID:RNF186 regulates EFNB1 (ephrin B1)-EPHB2-induced autophagy in the colonic epithelial cells for the maintenance of intestinal homeostasis. 3328 Apr 98